In triple-negative breast cancer (TNBC), studies have shown that chemotherapeutic agents targeting CAIX, such as SLC-0111, significantly increased extracellular pH while decreasing intracellular pH and extracellular lactate. Here, CA9 is linked to triple-negative breast carcinoma.